Worldwide Healthcare Trust PLC Edison issues review on Worldwide Healthcare Trust
February 08 2021 - 2:00AM
RNS Non-Regulatory
TIDMWWH
Worldwide Healthcare Trust PLC
08 February 2021
London, UK, 8 February 2021
Edison issues review on Worldwide Healthcare Trust (WWH)
Worldwide Healthcare Trust (WWH) is managed by Sven Borho and
Trevor Polischuk at global healthcare specialist OrbiMed. Although
the Democrats have regained control of the Senate, the managers
consider it more of a blue 'trickle' than a 'wave' as they won by
the narrowest of margins and they believe President Biden has far
more pressing issues to deal with than healthcare reform. Borho and
Polischuk are optimistic about the prospects for global healthcare
stocks this year, supported by a 'golden era' of innovation, a
constructive regulatory environment and the potential for robust
levels of mergers and acquisition (M&A) activity.
WWH's board regularly issues shares to manage the trust's
premium. It is currently trading at a 1.4% share price premium to
cum-income NAV, which compares with average premiums of 0.5% and
0.3% over the last one and three years and average discounts of
0.9% and 3.3% over the last five and 10 years respectively. Based
on its current share price, WWH offers a 0.7% yield.
Click here to view the full report.
All reports published by Edison are available to download free
of charge from its website
www.edisongroup.com
About Edison: E dison is a leading research and investor
relations consultancy, connecting listed companies to the widest
pool of global investors. By focusing on the volume and quality of
investors reached - across institutions, family offices, wealth
managers and retail investors - Edison can create and gauge intent
to purchase, even in the darkest pools of capital, and then make
introductions via non-deal roadshows, events or virtual
meetings.
Having been the first in-market 17 years ago, Edison now has
more than 100 analysts covering every economic sector.
Headquartered in London, Edison also has offices in New York,
Frankfurt, Amsterdam and Tel Aviv and a presence in Athens,
Johannesburg and Sydney.
Edison is authorised and regulated by the Financial Conduct
Authority .
Edison is not an adviser or broker-dealer and does not provide
investment advice. Edison's reports are not solicitations to buy or
sell any securities.
For more information, please contact Edison:
Mel Jenner, +44 (0)20 3077 5720,
investmenttrusts@edisongroup.com
Sarah Godfrey, +44 (0)20 3681 2519,
investmenttrusts@edisongroup.com
Learn more at www.edisongroup.com and connect with Edison on:
LinkedIn https://www.linkedin.com/company/edison-group-/
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRATAMITMTJMBFB
(END) Dow Jones Newswires
February 08, 2021 02:00 ET (07:00 GMT)
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024